Comparison | Standard Dose Model OR (95% CI) |
Unadjusted Dose Model OR (95% CI) |
Dose Adjusted Model OR (95% CI) |
Adalimumab vs Etanercept | 0.74 (0.36 to 1.45) | 1.04 (0.51 to 2.02) | 0.72 (0.34 to 1.51) |
Certolizumab vs Etanercept | 0.85 (0.39 to 1.77) | 1.02 (0.44 to 2.32) | 0.98 (0.48 to 1.99) |
Golimumab vs Etanercept | 0.90 (0.43 to 1.83) | 1.03 (0.42 to 2.51) | 0.96 (0.47 to 1.92) |
Abatacept vs Etanercept | 0.90 (0.40 to 1.94) | 0.90 (0.38 to 2.10) | 1.03 (0.49 to 2.16) |
Infliximab vs Etanercept | 1.12 (0.54 to 2.22) | 1.81 (0.89 to 3.68) | 1.21 (0.61 to 2.32) |
Rituximab vs Etanercept | 1.11 (0.31 to 3.80) | 2.11 (0.30 to 22.4) | 1.06 (0.35 to 3.19) |
Anakinra vs Etanercept | 1.04 (0.45 to 2.36) | 1.26 (0.45 to 3.34) | 1.15 (0.53 to 2.48) |
Tocilizumab vs Etanercept | 0.95 (0.34 to 2.54) | 1.41 (0.43 to 4.53) | 0.92 (0.37 to 2.25) |
Certolizumab vs Adalimumab | 1.14 (0.60 to 2.24) | 0.98 (0.43 to 2.33) | 1.37 (0.68 to 2.76) |
Golimumab vs Adalimumab | 1.20 (0.65 to 2.30) | 1.00 (0.40 to 2.49) | 1.34 (0.68 to 2.65) |
Abatacept vs Adalimumab | 1.22 (0.61 to 2.45) | 0.87 (0.37 to 2.09) | 1.44 (0.70 to 3.00) |
Infliximab vs Adalimumab | 1.51 (0.84 to 2.76) | 1.74 (0.86 to 3.70) | 1.68 (0.88 to 3.20) |
Rituximab vs Adalimumab | 1.50 (0.45 to 4.93) | 2.04 (0.30 to 22.18) | 1.49 (0.50 to 4.45) |
Anakinra vs Adalimumab | 1.40 (0.69 to 3.00) | 1.21 (0.44 to 3.32) | 1.60 (0.75 to 3.45) |
Tocilizumab vs Adalimumab | 1.27 (0.51 to 3.29) | 1.36 (0.42 to 4.43) | 1.29 (0.52 to 3.15) |
Golimumab vs Certolizumab | 1.06 (0.53 to 2.10) | 1.01 (0.35 to 2.78) | 0.98 (0.51 to 1.87) |
Abatacept vs Certolizumab | 1.07 (0.50 to 2.22) | 0.88 (0.33 to 2.31) | 1.06 (0.53 to 2.11) |
Infliximab vs Certolizumab | 1.32 (0.68 to 2.53) | 1.77 (0.75 to 4.22) | 1.23 (0.67 to 2.25) |
Rituximab vs Certolizumab | 1.31 (0.38 to 4.40) | 2.07 (0.28 to 23.37) | 1.09 (0.37 to 3.20) |
Anakinra vs Certolizumab | 1.22 (0.57 to 2.73) | 1.23 (0.40 to 3.65) | 1.17 (0.57 to 2.43) |
Tocilizumab vs Certolizumab | 1.11 (0.42 to 2.94) | 1.39 (0.39 to 4.85) | 0.94 (0.39 to 2.22) |
Abatacept vs Golimumab | 1.01 (0.49 to 2.07) | 0.87 (0.31 to 2.48) | 1.08 (0.55 to 2.13) |
Infliximab vs Golimumab | 1.26 (0.66 to 2.33) | 1.75 (0.70 to 4.54) | 1.26 (0.70 to 2.26) |
Rituximab vs Golimumab | 1.25 (0.36 to 4.07) | 2.05 (0.27 to 24.09) | 1.11 (0.38 to 3.23) |
Anakinra vs Golimumab | 1.16 (0.55 to 2.52) | 1.22 (0.38 to 3.90) | 1.19 (0.59 to 2.47) |
Tocilizumab vs Golimumab | 1.06 (0.41 to 2.74) | 1.36 (0.37 to 5.12) | 0.96 (0.41 to 2.26) |
Infliximab vs Abatacept | 1.24 (0.65 to 2.39) | 2.01 (0.87 to 4.77) | 1.17 (0.63 to 2.14) |
Rituximab vs Abatacept | 1.23 (0.35 to 4.23) | 2.35 (0.32 to 26.50) | 1.03 (0.34 to 3.11) |
Anakinra vs Abatacept | 1.15 (0.52 to 2.66) | 1.40 (0.45 to 4.33) | 1.11 (0.52 to 2.38) |
Tocilizumab vs Abatacept | 1.05 (0.39 to 2.8) | 1.57 (0.44 to 5.65) | 0.90 (0.37 to 2.17) |
Rituximab vs Infliximab | 0.99 (0.30 to 3.24) | 1.16 (0.17 to 12.87) | 0.88 (0.31 to 2.51) |
Anakinra vs Infliximab | 0.93 (0.45 to 1.98) | 0.70 (0.24 to 1.91) | 0.95 (0.49 to 1.89) |
Tocilizumab vs Infliximab | 0.84 (0.33 to 2.16) | 0.78 (0.24 to 2.54) | 0.77 (0.34 to 1.73) |
Anakinra vs Rituximab | 0.93 (0.27 to 3.44) | 0.59 (0.05 to 4.61) | 1.08 (0.35 to 3.29) |
Tocilizumab vs Rituximab | 0.85 (0.21 to 3.50) | 0.67 (0.05 to 5.67) | 0.87 (0.25 to 2.89) |
Tocilizumab vs Anakinra | 0.91 (0.32 to 2.52) | 1.12 (0.29 to 4.50) | 0.81 (0.32 to 1.99) |